Results 51 to 60 of about 741,475 (253)

Conquering C – Going Beyond Cure [PDF]

European Medical Journal Hepatology, 2015
Prof Zeuzem opened the symposium by acknowledging that there is a new era in hepatitis C virus (HCV) treatment, due to the availability of efficacious treatments that could eradicate the disease.
Stefan Zeuzem, Nezam H. Afdhal, Marc Bourlière, Graham Foster, Charles Gore, Jean-Michel Pawlotsky   +5 more
doaj  

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

, 1999
Hepatitis C is a global health problem caused by infection with the hepatitis C virus. Although representative prevalence data are not available from many countries, available data indicate that approximately 3% of the world's population is infected with
A.R. ZANETTI, WHO TECHNICAL CONSULTATION ON HEPATITIS C   +1 more
core   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Human hepatic met-enkephalin and delta opioid receptor-1 immunoreactivities in viral and autoimmune hepatitis

Annals of Hepatology, 2008
Endogenous opioids participate in growth regulation. Liver regeneration relates to growth. Thus, we explored the expression of methionine enkephalin and of the delta opioid receptor 1 immunoreactivities with a polyclonal rabbit antibody in deparaffinized
Vijaya D. Boyella, Anthony D. Nicastri, Nora V. Bergasa   +2 more
doaj   +1 more source

Envisioning a hepatitis delta cure with new antivirals

, 2021
Envisioning a hepatitis delta cure with new ...
Mendoza, Carmen de, Barreiro, Pablo, Corral, Octavio Jorge, Soriano, Vicente, Treviño, Ana, Corral, Octavio Jorge (1), Treviño, Ana (1), Soriano, Vicente (1), Carmen de Mendoza, Ana Treviño, Octavio Corral, Pablo Barreiro, Vicente Soriano   +12 more
core   +1 more source

Short‐Term Effects of Golden Rice Cookies Enriched With Piper crocatum Extract on Lipid Profiles in Adults With Diabetes: A Quasi‐Experimental Study

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) commonly coexists with dyslipidemia and elevated cardiovascular risk. Food‐based interventions containing antioxidants and polyphenols may support lipid metabolism. This study evaluated the short‐term effects of Golden Rice cookies enriched with active Piper crocatum extract on lipid profiles in adults with DM.
Altje Suwardi Abram, Andina Setyawati, Andi Masyitha Irwan   +2 more
wiley   +1 more source

Long\u2010term outcome of hepatitis delta in different regions world\u2010wide : results of the Hepatitis Delta International Network

: Background and Aims Chronic hepatitis delta represents a major global health burden. Clinical features of hepatitis D virus (HDV) infection vary largely between different regions worldwide.
Ceausu, Emanoil, Gherlan, George, Wranke, Anika, Keskin, Onur, Wedemeyer, Heiner, Buti, Maria, Turcanu, Adela, Vanwolleghem, Thomas, Niro, Grazia A., Ingiliz, Patrick, D\uf6rge, Petra, Yurdaydin, Cihan, Lobato, Cirley, Jachs, Mathias, Rizzetto, Mario, Dalekos, George N., Cornberg, Markus, Muche, Marion, Abbas, Minaam, Abbas, Zaigham   +19 more
core   +1 more source

Hepatitis delta in patients hospitalized in Spain (1997–2018)

, 2021
BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the last two decades.
Clara Ramos-Belinchón, Carmen de Mendoza, Antonio Aguilera, Pinargote-Celorio, Héctor, Ramos-Rincón, José-Manuel, Aguilera, Antonio, Ramos-Belinchón, Clara, Héctor Pinargote, José-Manuel Ramos-Rincon, Soriano, Vicente, Vicente Soriano, de Mendoza, Carmen, Soriano, Vicente (1)   +12 more
core   +1 more source

Multiscale Modeling of an 8‐Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection

Clinical Pharmacology &Therapeutics, EarlyView.
Bemnifosbuvir (BEM) and ruzasvir (RZR) are pan‐genotypic HCV polymerase (NS5B) and NS5A inhibitors, respectively. In a single‐arm study (NCT05904470), 215 treatment‐naïve, adherent participants with chronic HCV (with or without cirrhosis) received BEM 550 mg QD plus RZR 180 mg QD for 8 weeks.
Carolin Zitzmann, Ruy M. Ribeiro, Aurelien Marc, Xiao‐Jian Zhou, Alan S. Perelson   +4 more
wiley   +1 more source